MBOT

Microbot Medical Inc.

$1.05

-4.55%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Source: Yahoo Finance
AI summary

Price & performance

1M-9.2%
3M-37.4%
YTD-48.3%
1Y-49.5%
52-week range—
Beta1.69
Full chart and returns against a benchmark

Q-Score

47/ 100

Quality against peers; 50 is the peer median.

Growth36
Risk47
Performance53
Valuation53
Profitability48
Leverage61
Sentiment52
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue—
Net income-$13.1M
Net margin—
Historical fundamentals

Valuation

MBOTIndustryP/E—29.61P/S—3.49EV/EBITDA—18.38P/B1.023.39PEG——
Dividend yield0.00%
Every valuation metric